HSDT logo

SOLANA CO

HSDTNASDAQ
🏆 #3834 by market capEarnings Nov 16US Equity
$2.25▼ $0.03 (−1.32%)
After hours · at close
🔔
Track HSDT
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 1.3%
7d▼ 1.1%
14d▼ 4.3%
30d▼ 21.6%
ytd▼ 22.7%
1y▼ 66.2%
🏦Market Cap
$146M
Small Cap
📈Revenue Growth (YoY)
3992.2%
High Growth
📊Gross Margin
95.5%
High
💵FCF Margin
—
⚖️P/S Ratio
11.2x
Elevated
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$2.21 – $2.32
52-Week Range
$1.19 – $7.21
Volume (shares)
31,538
Avg Volume (shares)
—
Shares Outstanding
65.1M
Next Earnings
2026-11-16

Fundamentals Snapshot

Annual Revenue
$6M
Last Q Revenue
$3M
P/E Ratio
—
P/S Ratio
11.2x
EPS (TTM)
$-30.29
Dividend Yield
—
Dilution (1yr)
+713.6%
HSDT logo

SOLANA CO

HSDT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$6M▲ +1057.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
91.7%▼ −869.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$21M▲ +51.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$61M▲ +454.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
22.0M▲ +713.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▲ +$6M YoY
StockOtter · stockotter.space

About SOLANA CO

Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100

Analyst Ratings

ⓘ
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.